Patents Assigned to MGENPLUS CO., LTD.
  • Transgenic cloned piglet expressing human proinsulin and method of producing the same
    Patent number: 11149284
    Abstract: A transgenic cloned piglet expressing human proinsulin and a method of preparing the same, and more particularly, to a recombinant vector for human proinsulin expression, a genetically modified cell line into which the recombinant vector is introduced, a transgenic cloned piglet expressing human proinsulin, and a method of producing the same.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: October 19, 2021
    Assignee: MGENPLUS CO., LTD.
    Inventors: Jung-Taek Kang, Bumrae Cho, Su Jin Kim, Dal Young Ji, Eun Jin Lee, Sun Mi Ahn, Jin Seok Lee